Potential delay of the onset of clinical Type 1 diabetes
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
Dr Ross Walker speaks with Professor John Wentworth, Endocrinologist and Senior Clinical Research Fellow at St Vincent's Institute of Medical Research. We discuss the TGA’s historic registration of Tzield, the very first non-insulin medicine designed to delay the onset of clinical Type 1 diabetes.
To find out more go to https://breakthrought1d.org.au/news/tzield-approved-in-australia/
See omnystudio.com/listener for privacy information.
adbl_web_anon_alc_button_suppression_t1
No reviews yet